Spots Global Cancer Trial Database for urlc10
Every month we try and update this database with for urlc10 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer | NCT01069640 | Non-small Cell ... | HLA-A*0201 or H... | 20 Years - 85 Years | Shiga University | |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | NCT00681330 | Esophageal Canc... | URC10, TTK, KOC... | 20 Years - 85 Years | Tokyo University | |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer | NCT01069640 | Non-small Cell ... | HLA-A*0201 or H... | 20 Years - 85 Years | Shiga University | |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | NCT00681577 | Gastric Cancer | URLC10, KOC1, V... | 20 Years - 85 Years | Tokyo University | |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer | NCT01069640 | Non-small Cell ... | HLA-A*0201 or H... | 20 Years - 85 Years | Shiga University | |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer | NCT00753844 | Esophageal Canc... | URLC10 | 20 Years - 80 Years | Kinki University | |
| Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | NCT00681252 | Gastric Cancer | URLC10, VEGFR1 ... | 20 Years - 85 Years | Tokyo University | |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer | NCT00753844 | Esophageal Canc... | URLC10 | 20 Years - 80 Years | Kinki University | |
| Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | NCT00673777 | Non Small Cell ... | URLC10, VEGFR1 ... | 20 Years - 85 Years | Tokyo University | |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | NCT00674258 | Non Small Cell ... | URLC10, TTK and... | 20 Years - 85 Years | Tokyo University | |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | NCT00681577 | Gastric Cancer | URLC10, KOC1, V... | 20 Years - 85 Years | Tokyo University | |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer | NCT00845611 | Gastric Cancer | peptide vaccine | 20 Years - 80 Years | Kinki University | |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer | NCT01069575 | Non-Small Cell ... | HLA-A*2402restr... | 20 Years - 85 Years | Shiga University | |
| PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer | NCT00669292 | Esophageal Canc... | URLC10-177, TTK... | 20 Years - 80 Years | Wakayama Medical University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
